Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s traded shares stood at 0.32 million during the last session, with the company’s beta value hitting 1.61. At the close of trading, the stock’s price was $1.77, to imply a decrease of -11.50% or -$0.23 in intraday trading. The BDRX share’s 52-week high remains $74.00, putting it -4080.79% down since that peak but still an impressive -3.95% since price per share fell to its 52-week low of $1.84. The company has a valuation of $1.03M, with an average of 6.72 million shares in intraday trading volume over the past 10 days and average of 1.58 million shares over the past 3 months.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information
After registering a -11.50% downside in the last session, Biodexa Pharmaceuticals Plc ADR (BDRX) has traded red over the past five days. The 5-day price performance for the stock is -6.84%, and -53.42% over 30 days. With these gigs, the year-to-date price performance is -56.30%. Short interest in Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) saw shorts transact 36118.0 shares and set a 0.03 days time to cover.
Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts
The rating firms project that company’s revenue will shrink -100.00% compared to the previous financial year.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 86.34% for the past 5-year period. While 2025 is set for a 99.87% return in earnings, projections for the next 5 years are at 89.98% annually.
BDRX Dividends
Biodexa Pharmaceuticals Plc ADR has its next earnings report out in April. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s Major holders
Biodexa Pharmaceuticals Plc ADR insiders hold 8.82% of total outstanding shares, with institutional holders owning 29.86% of the shares at 32.75% float percentage. In total, 29.86% institutions holds shares in the company.
Going by data provided on Dec 31, 2024 , Fidelity Nasdaq Composite Index Fund holds roughly 78.0 shares. This is just over 0.00% of the total shares, with a market valuation of $138.0
